Human HSP-60/HSPD1(Heat Shock Protein 60) ELISA Kit from Reed Biotech Read more ›
Human HSP-60/HSPD1(Heat Shock Protein 60) ELISA Kit is a research-use ELISA kit from Reed Biotech for measuring HSP-60/HSPD1(Heat Shock Protein 60) in Serum, Plasma, Tissue homogenates, Other biological fluids samples from Human. Use the listed assay range, sample guidance and protocol documents to assess suitability for the intended study.
The assay format is Sandwich ELISA. Sensitivity is listed as 0.94 ng/mL. The detection range is listed as 1.57-100ng/mL. The listed reaction time is 3.5H. Listed sample types include Serum, Plasma, Tissue homogenate, Other biological samples. The listed sample volume is 100μL.
Alternative names include 60 kDa chaperonin, Chaperonin 60, cpn60, GROEL, heat shock 60kD protein 1 (chaperonin), heat shock 60kDa protein 1 (chaperonin), Heat shock protein 60, heat shock protein 65, HLD4, HSP60, HSP-60, HSP60SPG13, HSP65, HSPD1, HuCHA60, Mitochondrial matrix protein P1,60 kDa heat shock protein, mitochondrial, P60 lymphocyte protein, short heat shock protein 60 Hsp60s1, spastic paraplegia 13 (autosomal dominant), SPG13. Research areas include Neuro science;. The kit uses a colourimetric HRP/TMB ELISA workflow and is supplied for research use only.
| Collaborator | Reed Biotech |
| Partner model | RE2083H |
| Target | HSP-60/HSPD1(Heat Shock Protein 60) |
| Research areas | Neuro science |
| Reactivity | Human |
| Applications | ELISA |
| Assay type | Sandwich ELISA |
| Sample types | Serum,Plasma,Tissue homogenates,Other biological fluids |
| Detection range | 1.57-100ng/mL |
| Sensitivity | 0.94 ng/mL |
| Shelf life | Unopened kit: 2-8°C for 6 months |
| Availability | Order now, ship in 3 days |
| Lead time | 3 days |
| Sample Type | SERUM | PLASMA (EDTA) | URINE | CSF | CELL SUPERNATANT |
|---|---|---|---|---|---|
| Sample compatibility |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
For research applications. Not for diagnostic use.
No customer reviews yet.
